Last reviewed · How we verify
Placebo(for Rosuvastatin 10mg)
Placebo(for Rosuvastatin 10mg) is a Small molecule drug developed by IlDong Pharmaceutical Co Ltd. It is currently in Phase 3 development for Control in clinical trials for cardiovascular diseases.
Placebo does not have a pharmacological effect.
Placebo does not have a pharmacological effect. Used for Control in clinical trials for cardiovascular diseases.
At a glance
| Generic name | Placebo(for Rosuvastatin 10mg) |
|---|---|
| Sponsor | IlDong Pharmaceutical Co Ltd |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it serves as a control in clinical trials to compare the efficacy of the active drug, Rosuvastatin 10mg, without any actual therapeutic effect.
Approved indications
- Control in clinical trials for cardiovascular diseases
Common side effects
Key clinical trials
- A Phase 1 Study of PROT-001. (PHASE1)
- Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART) (PHASE3)
- Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP) (PHASE1)
- Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects (PHASE1)
- Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD (PHASE4)
- Statin Monotherapy for Treatment of Endocrine Metabolic Disease Risk (PHASE2)
- To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors (PHASE2)
- Statins for Acutely Injured Lungs From Sepsis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo(for Rosuvastatin 10mg) CI brief — competitive landscape report
- Placebo(for Rosuvastatin 10mg) updates RSS · CI watch RSS
- IlDong Pharmaceutical Co Ltd portfolio CI